Poland is leading the way in Europe with a new law enacted as of December 1, 2008 that prohibits medical representatives from visiting doctors during business hours. Reps are a good source of spoon-fed science for docs, not to mention the free samples and perks at conferences. However – over 90,000 doctors in Poland have quickly adjusted to a new reality and the big pharmas like GSK, Roche, Schering-Plough / Merck have accepted that times are a changing.
Current sales indicators of how many face to face visits a rep made are not going to cut it anymore. The question is – what next?

CLINICAL TRIAL READINESS ASSESSMENT
Are you really ready to run a clinical trial? How can you best assess your clinical trial readiness? We work with C-level executives and management